Characteristics and treatment pathways of COPD patients initiating single-inhaler dual or triple therapy in England

被引：0
|
作者：
Noorduyn, Stephen G. [1 ]
Wood, Robert P. [2 ]
Rothnie, Kieran J. [3 ]
Rai, Kiran K. [2 ]
Seif, Monica [2 ]
Massey, Lucy [2 ]
Compton, Chris [4 ]
Ismaila, Afisi S. [5 ,6 ]
机构：
[1] GSK, Value Evidence & Outcomes, R&D Global Med, Mississauga, ON, Canada
[2] Adelphi Real World, Real World Evidence, Bollington, Cheshire, England
[3] GSK, R&D Global Med, Value Evidence & Outcomes, Brentford, Middx, England
[4] GSK, Global Med, Brentford, Middx, England
[5] GSK, R&D Global Med, Value Evidence & Outcomes, Collegeville, PA USA
[6] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada
来源：
EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷
关键词：
D O I：
10.1183/13993003.congress-2023.PA2393
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Single-Inhaler Triple versus Dual Therapy in Patients with COPD
    Rolla, Giovanni
    Brussino, Luisa
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (06): : 590 - 591
  • [2] Single-Inhaler Triple versus Dual Therapy in Patients with COPD Reply
    Lipson, David A.
    Criner, Gerard J.
    Lomas, David A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (06): : 592 - 593
  • [3] The IMPACT of triple versus dual single-inhaler therapy on exacerbations of COPD
    Dobler, Claudia C.
    BREATHE, 2018, 14 (04) : 333 - 335
  • [4] Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD
    Lipson, David A.
    Barnhart, Frank
    Brealey, Noushin
    Brooks, Jean
    Criner, Gerard J.
    Day, Nicola C.
    Dransfield, Mark T.
    Halpin, David M. G.
    Han, MeiLan K.
    Jones, C. Elaine
    Kilbride, Sally
    Lange, Peter
    Lomas, David A.
    Martinez, Fernando J.
    Singh, Dave
    Tabberer, Maggie
    Wise, Robert A.
    Pascoe, Steven J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (18): : 1671 - 1680
  • [5] Benefit of prompt initiation of single-inhaler triple therapy in COPD patients in England following an exacerbation
    Ismaila, A.
    Wood, R.
    Czira, A.
    Banks, V
    Camidge, L.
    Massey, O.
    Sharma, R.
    Compton, C.
    Rothnie, K.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [6] Comparative Effectiveness and Safety of Single-Inhaler Triple Therapy for COPD
    Feldman, William B.
    Suissa, Samy
    Kesselheim, Aaron
    Avorn, Jerry
    Russo, Massimiliano
    Schneeweiss, Sebastian
    Wang, Shirley V.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 683 - 684
  • [7] Benefit/Risk Profile of Single-Inhaler Triple Therapy in COPD
    Bourbeau, Jean
    Bafadhel, Mona
    Barnes, Neil C.
    Compton, Chris
    Di Boscio, Valentina
    Lipson, David A.
    Jones, Paul W.
    Martin, Neil
    Weiss, Gudrun
    Halpin, David M. G.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2021, 16 : 499 - 517
  • [8] Single-inhaler triple therapy in symptomatic COPD patients: FULFIL subgroup analyses
    Halpin, David M. G.
    Birk, Ruby
    Brealey, Noushin
    Criner, Gerard J.
    Dransfield, Mark T.
    Hilton, Emma
    Lomas, David A.
    Zhu, Chang-Qing
    Lipson, David A.
    ERJ OPEN RESEARCH, 2018, 4 (02)
  • [9] Characteristics of COPD patients treated with single-inhaler triple therapy in real-life clinical practice
    Lassan, S.
    Keszegh, J.
    Lassanova, M.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2022, 123 (01): : 27 - 36
  • [10] CLINICAL AND ECONOMIC BENEFITS OF PROMPT INITIATION OF SINGLE-INHALER TRIPLE THERAPY IN COPD PATIENTS IN ENGLAND FOLLOWING AN EXACERBATION
    Ismaila, A. S.
    Wood, R. P.
    Czira, A.
    Banks, V. L.
    Camidge, L. J.
    Massey, O. K.
    Sharma, R.
    Compton, C.
    Rothnie, K.
    VALUE IN HEALTH, 2022, 25 (12) : S219 - S220
12345